Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Chimeric antigen receptor (CAR)-T cell therapy is effective against blood cancers.
• CAR-T cell therapy shows potential for solid tumors but faces significant obstacles.
• The tumor microenvironment (TME) plays a critical role in limiting CAR-T cell efficacy.

Purpose of the Study:

• To review the immunosuppressive mechanisms within the tumor microenvironment that hinder CAR-T cell function.
• To discuss strategies for overcoming TME-mediated inhibition of CAR-T cells in solid tumors.

Main Methods:

• Literature review of studies investigating CAR-T cell therapy in solid tumors.
• Analysis of the key inhibitory factors present in the tumor microenvironment.
• Synthesis of current approaches to enhance CAR-T cell activity against solid tumors.

Main Results:

• Upregulated inhibitory checkpoint receptors, suppressive cytokines, altered chemokine profiles, aberrant vasculature, stromal composition, hypoxia, and abnormal tumor metabolism are major immunosuppressive factors.
• These factors collectively impair the effector functions of CAR-T cells within the TME.
• Targeting these barriers is crucial for improving CAR-T cell efficacy.

Conclusions:

• The tumor microenvironment presents substantial barriers to effective CAR-T cell therapy for solid tumors.
• Overcoming TME-mediated immunosuppression through targeted strategies is essential for advancing CAR-T cell applications in solid tumor treatment.
• Further research into TME modulation is vital for unlocking the full potential of CAR-T cell immunotherapy.